Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Semaglutide is a GLP-1 receptor agonist approved for chronic weight management in adults with obesity (BMI 30 or higher) or overweight (BMI 27 to 29.9) who also have a weight-related condition, used together with a reduced-calorie diet and more physical activity
The small studies on knee pain and bladder pain are interesting, but they involved fewer than 30 patients total
While some insurance policies cover semaglutide GLP-1 for weight loss, coverage eligibility, and reimbursement amounts are variable
Beneficiaries who already receive a GLP-1 through their Part D plan for a covered Medicare indication such as type 2 diabetes, cardiovascular risk reduction, or obstructive sleep apnea will continue accessing the drug through their regular Part D plan rather than through the Bridge
US$ 29.10
US$ 23.28
.png.jpg)
US$ 23.70
US$ 24.43
US$ 27.92
US$ 21.57
